Cardiovascular Disease and mTOR Signaling

Trends in Cardiovascular Medicine

Volumn 21, Issue 5, 2011, Pages 151-155

  Chong, Zhao Zhong ^a   Shang, Yan Chen ^a   Maiese, Kenneth ^a,b  

^a New Jersey Health Sciences University   (United States)

^b RUTGERS CANCER INSTITUTE OF NEW JERSEY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MAMMALIAN TARGET OF RAPAMYCIN; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 1; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 2;

ANGIOGENESIS; APOPTOSIS; AUTOPHAGY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR SYSTEM; CELL PROLIFERATION; HEART PROTECTION; HUMAN; ISCHEMIA; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; STEM CELL;

CARDIOVASCULAR DISEASES; HUMANS; SIGNAL TRANSDUCTION; TOR SERINE-THREONINE KINASES;

EID: 84862726562     PISSN: 10501738     EISSN: 18732615     Source Type: Journal    
DOI: 10.1016/j.tcm.2012.04.005     Document Type: Review

References (40)

1. Ammar H.I., Saba S., Ammar R.I., et al. Erythropoietin protects against doxorubicin-induced heart failure. Am J Physiol Heart Circ Physiol 2011, 301:H2413-H2421.
2. Chen C., Liu Y., Zheng P. mTOR regulation and therapeutic rejuvenation of aging hematopoietic stem cells. Sci Signal 2009, 2:ra75.
3. Chong Z.Z., Hou J., Shang Y.C., et al. EPO relies upon novel signaling of Wnt1 that requires Akt1, FoxO3a, GSK-3β, and β-catenin to foster vascular integrity during experimental diabetes. Curr Neurovasc Res 2011, 8:103-120.
4. Chong Z.Z., Li F., Maiese K. Oxidative stress in the brain: Novel cellular targets that govern survival during neurodegenerative disease. Prog Neurobiol 2005, 75:207-246.
5. Chong Z.Z., Shang Y.C., Zhang L., et al. Mammalian target of rapamycin: Hitting the bull's-eye for neurological disorders. Oxid Med Cell Longev 2010, 3:374-391.
6. Das J., Ghosh J., Manna P., Sil P.C. Taurine suppresses doxorubicin-triggered oxidative stress and cardiac apoptosis in rat via up-regulation of PI3-K/Akt and inhibition of p53, p38-JNK. Biochem Pharmacol 2011, 81:891-909.
7. Dormond O., Madsen J.C., Briscoe D.M. The effects of mTOR-Akt interactions on anti-apoptotic signaling in vascular endothelial cells. J Biol Chem 2007, 282:23679-23686.
8. Easley C.A., Ben-Yehudah A., Redinger C.J., et al. mTOR-mediated activation of p70 S6K induces differentiation of pluripotent human embryonic stem cells. Cell Reprogram 2010, 12:263-273.
9. Földes G., Mioulane M., Wright J.S., et al. Modulation of human embryonic stem cell-derived cardiomyocyte growth: A testbed for studying human cardiac hypertrophy?. J Mol Cell Cardiol 2011, 50:367-376.
10. Gangloff Y.G., Mueller M., Dann S.G., et al. Disruption of the mouse mTOR gene leads to early postimplantation lethality and prohibits embryonic stem cell development. Mol Cell Biol 2004, 24:9508-9516.
11. Hernández G., Lal H., Fidalgo M., et al. A novel cardioprotective p38-MAPK/mTOR pathway. Exp Cell Res 2011, 317:2938-2949.
12. Huang J., Zhang Y., Bersenev A., et al. Pivotal role for glycogen synthase kinase-3 in hematopoietic stem cell homeostasis in mice. J Clin Invest 2009, 119:3519-3529.
13. Humar R., Kiefer F.N., Berns H., et al. Hypoxia enhances vascular cell proliferation and angiogenesis in vitro via rapamycin (mTOR)-dependent signaling. FASEB J 2002, 16:771-780.
14. Hwang S.K., Kim H.H. The functions of mTOR in ischemic diseases. BMB Rep 2011, 44:506-511.
15. Jaber N., Dou Z., Chen J.S., et al. Class III PI3K Vps34 plays an essential role in autophagy and in heart and liver function. Proc Natl Acad Sci USA 2012, 109:2003-2008.
16. Kim J., Jung Y., Sun H., et al. Erythropoietin mediated bone formation is regulated by mTOR signaling. J Cell Biochem 2012, 113:220-228.
17. Lajoie C., El-Helou V., Proulx C., et al. Infarct size is increased in female post-MI rats treated with rapamycin. Can J Physiol Pharmacol 2009, 87:460-470.
18. Lemaître V., Dabo A.J., D'Armiento J. Cigarette smoke components induce matrix metalloproteinase-1 in aortic endothelial cells through inhibition of mTOR signaling. Toxicol Sci 2011, 123:542-549.
19. Maiese K., Chong Z.Z., Hou J., Shang Y.C. Oxidative stress: Biomarkers and novel therapeutic pathways. Exp Gerontol 2010, 45:217-234.
20. Maiese K., Chong Z.Z., Shang Y.C., Hou J. FoxO proteins: Cunning concepts and considerations for the cardiovascular system. Clin Sci (London) 2009, 116:191-203.
21. Maiese K., Li F., Chong Z.Z. New avenues of exploration for erythropoietin. JAMA 2005, 293:90-95.
22. Maiese K., Li F., Chong Z.Z., Shang Y.C. The Wnt signaling pathway: Aging gracefully as a protectionist?. Pharmacol Ther 2008, 118:58-81.
23. Mancini D., Pinney S., Burkhoff D., et al. Use of rapamycin slows progression of cardiac transplantation vasculopathy. Circulation 2003, 108:48-53.
24. Miriuka S.G., Rao V., Peterson M., et al. mTOR inhibition induces endothelial progenitor cell death. Am J Transplant 2006, 6:2069-2079.
25. Murakami M., Ichisaka T., Maeda M., et al. mTOR is essential for growth and proliferation in early mouse embryos and embryonic stem cells. Mol Cell Biol 2004, 24:6710-6718.
26. Nascimento E.B., Snel M., Guigas B., et al. Phosphorylation of PRAS40 on Thr246 by PKB/AKT facilitates efficient phosphorylation of Ser183 by mTORC1. Cell Signal 2010, 22:961-967.
27. Ogura Y., Iemitsu M., Naito H., et al. Single bout of running exercise changes LC3-II expression in rat cardiac muscle. Biochem Biophys Res Commun 2011, 414:756-760.
28. Pastor M.D., García-Yébenes I., Fradejas N., et al. mTOR/S6 kinase pathway contributes to astrocyte survival during ischemia. J Biol Chem 2009, 284:22067-22078.
29. Popescu N.I., Lupu C., Lupu F. Extracellular protein disulfide isomerase regulates coagulation on endothelial cells through modulation of phosphatidylserine exposure. Blood 2010, 116:993-1001.
30. Schips T.G., Wietelmann A., Höhn K., et al. FoxO3 induces reversible cardiac atrophy and autophagy in a transgenic mouse model. Cardiovasc Res 2011, 91:587-597.
31. Shang Y.C., Chong Z.Z., Wang S., Maiese K. Erythropoietin and Wnt1 govern pathways of mTOR, Apaf-1, and XIAP in inflammatory microglia. Curr Neurovasc Res 2011, 8:270-285.
32. Shang Y.C., Chong Z.Z., Wang S., Maiese K. Prevention of beta-amyloid degeneration of microglia by erythropoietin depends on Wnt1, the PI 3-K/mTOR pathway, Bad, and Bcl-xL. Aging (Albany) 2012, 4:187-201.
33. Sinha S.S., Pham M.X., Vagelos R.H., et al. Effect of rapamycin therapy on coronary artery physiology early after cardiac transplantation. Am Heart J 2008, 155:889. e1-e6.
34. Thedieck K., Polak P., Kim M.L., et al. PRAS40 and PRR5-like protein are new mTOR interactors that regulate apoptosis. PLoS One 2007, 2:e1217.
35. Vigneron F., Dos Santos P., Lemoine S., et al. GSK-3β at the crossroads in the signalling of heart preconditioning: Implication of mTOR and Wnt pathways. Cardiovasc Res 2011, 90:49-56.
36. Wagner C., Tillack D., Simonis G., et al. Ischemic post-conditioning reduces infarct size of the in vivo rat heart: Role of PI3-K, mTOR, GSK-3beta, and apoptosis. Mol Cell Biochem 2010, 339:135-147.
37. Xin X.Y., Pan J., Wang X.Q., et al. 2-Methoxyestradiol attenuates autophagy activation after global ischemia. Can J Neurol Sci 2011, 38:631-638.
38. Zhang D., Contu R., Latronico M.V., et al. MTORC1 regulates cardiac function and myocyte survival through 4E-BP1 inhibition in mice. J Clin Invest 2010, 120:2805-2816.
39. Zhao Y., Xue T., Yang X., et al. Autophagy plays an important role in Sunitinib-mediated cell death in H9c2 cardiac muscle cells. Toxicol Appl Pharmacol 2010, 248:20-27.
40. Zhou J., Su P., Wang L., et al. mTOR supports long-term self-renewal and suppresses mesoderm and endoderm activities of human embryonic stem cells. Proc Natl Acad Sci USA 2009, 106:7840-7845.